Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870375 · ClinicalTrials.gov registry record
Longitudinal Studies of Brain Structure and Function in MPS Disorders
A clinical trial of Mucopolysaccharidosis Type I and Mucopolysaccharidosis Type II, sponsored by University of Minnesota.
- Completed
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT01870375 is a study of Mucopolysaccharidosis Type I and Mucopolysaccharidosis Type II that has completed, run by University of Minnesota. The registered enrollment target is 100 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT01870375, a study of Mucopolysaccharidosis Type I and Mucopolysaccharidosis Type II, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
Neurobehavioral function and quality of life are compromised in many patients with mucopolysaccharidosis (MPS) disorders. The long-term goals of this research are to: 1) more accurately inform patients/parents regarding potential neurobehavioral outcomes; 2) develop sensitive measures of disease progression and central nervous system (CNS) treatment outcome; and 3) help clinical researchers develop direct treatments for specific brain structures/functions. The investigators hypothesize that specific and localized neuroimaging and neuropsychological findings and their relationship will be distinct for each MPS disorder. It is further hypothesized that without treatment, functions will decline and structure will change over time in a predictable fashion, and will be related to locus of abnormality and stage of disease.
Conditions Studied
Study Locations (4)
California
- Oakland Children's Hospital - Oakland
Minnesota
- University of Minnesota - Minneapolis
New York
- New York University - New York
Ontario
- Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-09 |
| Est. Completion | 2019-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01870375
The ClinicalTrials.gov registry entry for NCT01870375 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Mucopolysaccharidosis Type I appearing as the primary indexed condition, and to 0 interventions.
NCT01870375 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT01870375 about?
NCT01870375 is a clinical study titled "Longitudinal Studies of Brain Structure and Function in MPS Disorders". Neurobehavioral function and quality of life are compromised in many patients with mucopolysaccharidosis (MPS) disorders. The long-term goals of this research are to: 1) more accurately inform patients/parents regarding potential neurobehavioral outcomes; 2) develop sensitive measures of disease pro...
What is the current status of trial NCT01870375?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-09. Estimated completion is 2019-08-31.
What conditions does trial NCT01870375 study?
This clinical trial studies the following conditions: Mucopolysaccharidosis Type I, Mucopolysaccharidosis Type II, Mucopolysaccharidosis Type VI, Mucopolysaccharidosis Type IV, Mucopolysaccharidosis Type VII.
Who is sponsoring clinical trial NCT01870375?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01870375 being conducted?
This trial has 4 study locations across California, Minnesota, New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mucopolysaccharidosis Type I
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Mucopolysaccharidosis Type I
All registered trials for this condition
Mucopolysaccharidosis Type II
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.